Next Article in Journal
Detection of Novel QTLs for Late Blight Resistance Derived from the Wild Potato Species Solanum microdontum and Solanum pampasense
Previous Article in Journal
Protective Mechanisms Against DNA Replication Stress in the Nervous System
Previous Article in Special Issue
Evaluation of the VISAGE Basic Tool for Appearance and Ancestry Prediction Using PowerSeq Chemistry on the MiSeq FGx System

This is an early access version, the complete PDF, HTML, and XML versions will be available soon.

Open AccessFeature PaperReview

Utility of Common Marmoset (Callithrix jacchus) Embryonic Stem Cells in Liver Disease Modeling, Tissue Engineering and Drug Metabolism

1
Department of Electrical and Computer Engineering, College of Science and Engineering, University of Minnesota, 200 Union Street S.E., Minneapolis, MN 55455, USA
2
Departments of Medicine and Genetics, Cell Biology and Development, University of Minnesota, 420 Delaware Street S.E, Minneapolis MN 55455, USA
*
Author to whom correspondence should be addressed.
Genes 2020, 11(7), 729; https://doi.org/10.3390/genes11070729
Received: 2 June 2020 / Revised: 21 June 2020 / Accepted: 25 June 2020 / Published: 30 June 2020
(This article belongs to the Special Issue Genes at Ten)
The incidence of liver disease is increasing significantly worldwide and, as a result, there is a pressing need to develop new technologies and applications for end-stage liver diseases. For many of them, orthotopic liver transplantation is the only viable therapeutic option. Stem cells that are capable of differentiating into all liver cell types and could closely mimic human liver disease are extremely valuable for disease modeling, tissue regeneration and repair, and for drug metabolism studies to develop novel therapeutic treatments. Despite the extensive research efforts, positive results from rodent models have not translated meaningfully into realistic preclinical models and therapies. The common marmoset Callithrix jacchus has emerged as a viable non-human primate model to study various human diseases because of its distinct features and close physiologic, genetic and metabolic similarities to humans. C. jacchus embryonic stem cells (cjESC) and recently generated cjESC-derived hepatocyte-like cells (cjESC-HLCs) could fill the gaps in disease modeling, liver regeneration and metabolic studies. They are extremely useful for cell therapy to regenerate and repair damaged liver tissues in vivo as they could efficiently engraft into the liver parenchyma. For in vitro studies, they would be advantageous for drug design and metabolism in developing novel drugs and cell-based therapies. Specifically, they express both phase I and II metabolic enzymes that share similar substrate specificities, inhibition and induction characteristics, and drug metabolism as their human counterparts. In addition, cjESCs and cjESC-HLCs are advantageous for investigations on emerging research areas, including blastocyst complementation to generate entire livers, and bioengineering of discarded livers to regenerate whole livers for transplantation.
Keywords: liver; marmoset; Callithrix jacchus; embryonic stem cell; transplantation; hepatocyte; liver disease; regeneration; drug metabolism; cell therapy; cytochrome P450; bioengineering liver; marmoset; Callithrix jacchus; embryonic stem cell; transplantation; hepatocyte; liver disease; regeneration; drug metabolism; cell therapy; cytochrome P450; bioengineering
MDPI and ACS Style

Aravalli, R.N.; Steer, C.J. Utility of Common Marmoset (Callithrix jacchus) Embryonic Stem Cells in Liver Disease Modeling, Tissue Engineering and Drug Metabolism. Genes 2020, 11, 729.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop